Catégorie
Numéro CAS
Hydrocortisone STD - 50-23-7 : IMP - D - 53-35-0 : IMP - E - 600-99-7 : IMP - G - 14760-49-7 : IMP - H - NA : IMP - I - 103795-84-2 : IMP - N - NA
Formule moléculaire
Hydrocortisone STD - C21H30O5 : IMP - D - C21H30O6: IMP - E - C21H28O5 : IMP - G - C21H28O5 : IMP - H - C21H30O6 : IMP - I - C21H30O6 : IMP - N - C42H58O10
Masse moléculaire
Hydrocortisone STD -362.46 g/mol : IMP - D - 378.46 g/mol : IMP - E - 360.44 g/mol : IMP - G - 360.44 g/mol : IMP - H - 378.46 g/mol : IMP - I - 378.46 g/mol : IMP - N - 722.90 g/mol
Synonyme

Hydrocortisone - (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one ; (11β)-11,17,21-Trihydroxy-pregn-4-ene-3,20-dione; 11β,17,21-Trihydroxypregn-4-ene-3,20-dione; 17-Hydroxycorticosterone; 17α-Hydroxycorticosterone; NSC 10483; Cortisol, Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11b) (USP);

Hydrocortisone EP Impurity -D - (6R,8S,9S,10R,11S,13S,14S,17R)-6,11,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one ; (6beta,11beta)-6,11,17,21-Tetrahydroxypregn-4-ene-3,20-dione6beta ;17-Dihydroxycorticosterone 6beta,11beta ;6β-Hydroxy Cortisol ;

Hydrocortisone EP Impurity -E - (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one ; Pregna-4,6-diene-3,20-dione,11,17,21-trihydroxy-,(11beta)-; 

Hydrocortisone EP Impurity -G - 11beta,17-Dihydroxy-3,20-dioxopregn-4-en-21-al ; 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde;

Hydrocortisone EP Impurity -H - 7alpha,11beta,17,21-Tetrahydroxypregn-4-ene-3,20-dione ; 7alpha-Hydroxyhydrocortisone ;Hydrocortisone EP Impurity -I - 11beta,14,17,21-Tetrahydroxypregn-4-ene-3,20-dione;

Hydrocortisone EP Impurity -N - 1-((10R,11S,13S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-4-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,3-dihydroxybutane-1,4-dione ; 

slide_1